Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine,General Medicine
Reference100 articles.
1. Bardelli A, Pantel K. Liquid biopsies, What we do not know (yet). Cancer Cell. 2017;31(2):172–9.
2. Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic—implementation issues and future challenges. Nat Rev Clin Oncol. 2021. https://doi.org/10.1038/s41571-020-00457-x (Epub ahead of print. PMID: 33473219.).
3. Oxnard GR, Thress KS, Alden RS, Lawrance R, Paweletz CP, Cantarini M, et al. Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer. J Clin Oncol. 2016;34:3375–82.
4. US Food & Drug Administration. Premarket approval P150044—Cobas EGFR MUTATION TEST V2.FDA. 2016. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150044.
5. André F, Ciruelos E, Juric D, Loibl S, Campone M, Mayer IA, et al. Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer. N Engl J Med. 2019;380:1929–40.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献